Facebook
Facebook
Twitter
Twitter
LinkedIn
LinkedIn
Email
Email
0 Comments
Comments
Like lead before it (and we all know how that turned out), bisphenol A is taking its turn in the spotlight, decked out in misinformation and escorted by ongoing controversy. Welcome to the party.
Before last week, it would seem the FDA had pretty much put this one to rest. But it didn’t really go away. In fact, it was really only a matter of time before someone brought this up again, and courtesy of The Washington Post, bring it up they did. Though I realize that, as a reporter, I “dig” for a living, it doesn’t take a backhoe to unearth that the FDA based its proclamation that BPA does not pose a safety concern on research funded by the American Plastics Council. Um, that sounds a little like a conflict of interest to me.
0 Comments
View Comments
Related Content
Comments